Skip to main content

Viking settlers of the Faroe Islands

Genetic evidence points to distinct Viking settlers of the Faroe Islands and Iceland


Geneticists have studied the distribution of Y-chromosome haplogroups on the Faroe Islands, known to have been colonized by Vikings around the year 900 CE, and compared these to distributions of haplogroups in today's Scandinavia.

They showed with novel analysis methods that the haplotype distribution in the Faroe Islands most closely resembled that in Norway and Denmark, and to a lesser extent that in Sweden, but differed from that in Iceland. They concluded that a band of Viking men from all over Scandinavia colonized the Faroe Islands, which differed in their geographical origin and genetic make-up from those who settled Iceland.

The ancient Vikings certainly had the travel bug. Between the late eighth century and approximately 1050 CE, they roamed the Atlantic in their longships all the way to Newfoundland, Labrador, and Greenland, as well as exploring the Mediterranean and continental Eurasia.

Among the places the Vikings are known to have settled were the Faroe Islands, an archipelago of 18 islands in the North Atlantic. They probably weren't the first to do so: Archaeologists have found evidence that these islands had been inhabited since approximately 300 CE, possibly by Celtic monks or others from the British Isles. But according to the Færeyinga Saga, written about 1200, a Viking chief called Grímur Kamban settled in the Faroe Islands between approximately 872 and 930 CE.

But where in Scandinavia did Grímur and his followers come from?

"Here we provide strong evidence that the Faroe Islands were colonized by a diverse group of male settlers from multiple Scandinavian populations," said Dr. Christopher Tillquist, an associate professor at the University of Louisville in Kentucky and the lead author of a new study published in Frontiers in Genetics.

Tillquist's co-authors were Dr. Allison Mann from the University of Wyoming and Dr. Eyðfinn Magnussen from the University of the Faroe Islands.

The scientists determined the genotype at 12 "short tandem repeat" (STR) loci on the Y-chromosome of 139 men from the Faroese islands of Borðoy, Streymoy, and Suðuroy. They assigned each man to the most likely haplogroup, each of which has different known distribution across today's Europe.

The researchers compared the distribution of genotypes to those found in 412 men from Norway, Sweden, Denmark, Iceland, and Ireland. This allowed them to reconstruct the source population of the Viking population founders.

Advanced analyses showed that the range of Faroese samples resembled the range of genotypes from broader Scandinavian, whereas the Icelandic genotypes were distinct.

The authors also developed a powerful innovative genetic method, called "Mutational Distance from Modal Haplotype" to analyze variation in SNPs (single-nucleotide polymorphisms) within the STRs. This allowed them to reveal a "founder effect"—traces of random loss of diversity during historical colonization by a small number of people—persisting in the genetic make-up of today's Faroese and Icelandic male populations.

"Scientists have long assumed that the Faroe Islands and Iceland were both settled by similar Norse people. Yet our novel analysis has shown that these islands were founded by men from different gene pools within Scandinavia," said Tillquist.

"One group, diverse in their Scandinavian origins, established themselves in the Faroe Islands, while another and more genetically divergent band of Vikings colonized Iceland. They have separate genetic signatures that persist to this day."

"There doesn't seem to have been any interbreeding afterwards between these two populations, despite their geographic proximity. Our results demonstrate that Viking expansion into the North Atlantic was more complex than previously thought."

"Each longship that set sail for these distant islands carried not just Vikings, but distinct genetic legacies. We can now trace these separate journeys of conquest and settlement, revealing a more nuanced story of Viking exploration than told by the history books."

Vikings, Faroe Islands, Norse settlers, Viking history, Viking Age, Faroese culture, Norse expansion, seafaring, Viking heritage, Norse mythology, Faroese archaeology, medieval Scandinavia, Viking trade, Norse farming, Viking longships, Faroese settlement, Norse exploration, Viking artifacts, Faroe Islands geography, Norse language, Viking influence, Faroe Islands history, Nordic heritage, Viking society, medieval Norse.

#Vikings, #FaroeIslands, #NorseSettlers, #VikingAge, #FaroeseCulture, #NorseExpansion, #Seafaring, #VikingHeritage, #NorseMythology, #FaroeseArchaeology, #ScandinavianHistory, #VikingTrade, #NorseFarming, #VikingLongships, #FaroeseSettlement, #NorseExploration, #VikingArtifacts, #FaroeGeography, #NorseLanguage, #VikingInfluence, #NordicHeritage, #FaroeHistory, #VikingSociety, #MedievalNorse, #NorseLegacy.

International Conference on Genetics and Genomics of Diseases 

Comments

Popular posts from this blog

Genetics role in ovarian cancer

The Medical Minute: Genetics play big role in ovarian cancer In 2024, about 19,680 women in the United States will receive a new diagnosis of ovarian cancer and 12,740 women will die from the disease, said Dr. Shaina Bruce , a gynecologic oncologist at Penn State Cancer Institute . The median age of all patients who develop ovarian cancer is 63. Historically, women at increased risk for ovarian cancer are recommended to have their fallopian tubes and ovaries removed when they have completed having children. Taking that step to protect themselves comes at a heavy price ― surgical menopause. But Bruce said medical science is catching up with ovarian cancer. Studies could lead to new methods for preventative care and the surgery needed to lower risk may be easier than it once was. Below, during Gynecologic Cancer Awareness Month, Bruce discusses the disease and why acting to reduce your risk is worth it. What’s the connection between heredity and ovarian cancer? About 25% of all cases of ...

X chromosome

Gene on the X chromosome may help explain high multiple sclerosis rates in women Brain inflammation may be fueled by a gene on the X chromosome, a new study in mice suggests. And in female mice, who carry two X chromosomes, a diabetes drug called metformin may work to counteract that inflammation. If these findings bear out in later studies, they could help to unravel the long-standing mystery of why women, who have two copies of this inflammation-driving gene, are more prone to certain autoimmune diseases, particularly after menopause. A disparity between the sexes Our bodies are patrolled by immune cells that provide protection against bacteria and viruses, but sometimes, these defenses turn on us. In the autoimmune disorder multiple sclerosis (MS), for instance, the immune system attacks myelin, the fatty insulation surrounding the nerve fibers in the brain and spinal cord. This leads to symptoms such as muscle weakness and difficulty walking, as well issues with memory and thinking...

Multifactorial Genetic Conditions

Multifactorial Genetic Conditions Multifactorial genetic conditions are disorders caused by the combined effects of multiple genes and environmental factors , rather than a single gene mutation . These conditions do not follow classic Mendelian inheritance patterns and instead result from complex gene–environment interactions . Factors such as lifestyle, nutrition, infections, stress, and exposure to toxins can significantly influence disease onset and severity in genetically susceptible individuals. Common examples include diabetes, cardiovascular diseases , neural tube defects, asthma, and many neuropsychiatric disorders. Understanding multifactorial inheritance is essential for risk prediction, preventive medicine, and personalized healthcare strategies. Multifactorial inheritance, polygenic traits, gene–environment interaction, complex diseases, genetic susceptibility, environmental risk factors, non-Mendelian inheritance, disease predisposition, polygenic risk score, precision ...